MustGrow Biologics enhances exposure to key Canadian phosphate market with RhizoSorb deal

MustGrow Biologics (MGRO) has expanded its NexusBioAg product line through a distribution agreement with Phospholutions to sell RhizoSorb in Canada, a key phosphate market with 94.5 million acres of crop production. Noble Capital Markets analysts highlight that RhizoSorb has demonstrated a 50% increase in phosphorus efficiency, potentially saving farmers up to US$20 per acre while also significantly reducing CO2 emissions and phosphorus runoff. Noble Capital Markets reiterated its 'Market Perform' rating on MustGrow, citing the NexusBioAg acquisition as providing an experienced sales team for both NexusBioAg's and MustGrow's products.

Analysis

MustGrow Biologics Corp. (MGRO) has strategically expanded its product offerings within the Canadian agricultural market through a distribution agreement with Phospholutions for the RhizoSorb product, facilitated by its NexusBioAg division. This agreement introduces a product with substantial backing, evidenced by over 500 trials, demonstrating a 50% increase in phosphorus efficiency and potential farmer savings up to US$20 per acre. Furthermore, RhizoSorb offers significant environmental advantages, including a 45.2% reduction in CO2 emissions and substantial decreases in phosphorus runoff (78%) and leaching (84%) compared to conventional fertilizers, positioning it well within the growing ESG investment theme. The Canadian market, with over 94.5 million acres of crop production reliant on phosphate, represents a key target for this enhanced efficiency product. Noble Capital Markets maintains a 'Market Perform' rating on MustGrow, highlighting the acquired NexusBioAg sales team's capability to leverage both existing and new products like RhizoSorb, and noting the substantial opportunity for natural alternatives in MustGrow's targeted end markets such as preplant soil fumigation and biofertility.

Key Decisions for Investors

• Investors should consider the potential for enhanced revenue and market share for MustGrow in the critical Canadian phosphate market, driven by the RhizoSorb distribution agreement and its compelling economic and environmental benefits.
• Given Noble Capital Markets' 'Market Perform' rating, investors should monitor the sales traction of RhizoSorb and the effective utilization of the NexusBioAg sales infrastructure as key indicators of MustGrow's ability to capitalize on this opportunity.
• The strong ESG profile of RhizoSorb may attract sustainability-focused investors and could provide a competitive advantage, warranting attention to its adoption rate and impact on MustGrow's overall growth trajectory in bio-agriculture.